| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0073 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00067 | 1 |